Betamethasone Dipropionate 0.05% / Niacinamide 4%
FDA Label NDC 72934-2026

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sincerus Florida, Llc for the product Betamethasone Dipropionate 0.05% / Niacinamide 4% (NDC 72934-2026). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding directions for use. as directed by physician. apply topically. for external use only. wash hands after use. store at controlled room temperature 20-25 celsius., sincerus florida, llc. adverse reactions, active, inactive, ndc 72934- 2026-2 betamethasone dipropionate usp 0.05% / niacinamide usp 4% cream 30 gm., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.